Article

Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers

2024-11-26

Abstract excerpt

The PD1/PD-L1 axis plays an important immunosuppressive role during the T cell mediated immune response, which is essential for the physiological homeostasis of the immune system. The biology of the immunological microenvironment is extremely complex and crucial for the development of treatment strategies for immunotherapy. Characterization of the immunological, genomic or transcriptomic landscape of cancer patien...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bcde62f1-e01e-535d-a3be-e6db4464dc69
DOI: 10.20944/preprints202411.2041.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on BiomarkersDOI 10.20944/preprints202411.2041.v1Read

Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on BiomarkersSemantic proximity Read

Complex regulatory network of programmed death-ligand 1 in cancer: Cancer immunomodulation from molecular mechanisms to clinical applicationsSemantic proximity Read

Revolutionizing Cancer Therapy: A Comprehensive Review of Immune Checkpoint InhibitorsSemantic proximity Read

Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical SettingSemantic proximity Read

PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applicationsSemantic proximity Read

Predictive Biomarkers for Immunotherapy Response Beyond PD-1/PD-L1.Semantic proximity Read

Regulatory mechanisms of PD-1/PD-L1 in cancersSemantic proximity Read

Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapySemantic proximity Read

Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to TherapySemantic proximity Read

Advances and prospects of biomarkers for immune checkpoint inhibitorsSemantic proximity Read

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancersSemantic proximity Read

Recent Findings in the Regulation of Programmed Death Ligand 1 ExpressionSemantic proximity Read